Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Study of Lornoxicam or Placebo for Acute Treatment of the Headache of Migraine.

ClinicalTrials.gov ID: NCT00293657

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00293657. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 16, 2026, 1:53 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Single-Dose Study, Placebo-Controlled Evaluation of the Safety and Efficacy of Intravenous Lornoxicam in the Acute Treatment of the Headache of Migraine.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To determine whether a single dose of intravenous lornoxicam is superior to intravenous placebo for the acute treatment of moderate or severe headache associated with a single migraine attack in patients with a history of migraine. Two-thirds of patients in this study will receive a single dose of intravenous lornoxicam (8mg or 16 mg) and one-third of patients will receive a single dose of an intravenous placebo.

Study identification

NCT ID
NCT00293657
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
POZEN
Industry
Enrollment
150 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2005 (Type not available)
Primary completion
Apr 2006 (Actual)
Completion
Apr 2006 (Actual)
Last update posted
Dec 3, 2012

2005 – 2006

United States locations

U.S. sites
23
U.S. states
17
U.S. cities
23
Facility City State ZIP Site status
Alabama Clinical Therapeutics Birmingham Alabama 35235 —
University of South Alabama Neurology Mobile Alabama 36693 —
Little Rock Family Practice Clinic Little Rock Arkansas 72205 —
C. Phillip O'Carroll, MD, Inc. Newport Beach California 92660 —
California Medical Clinic for Headache Santa Monica California 90404 —
New England Center for Headache Stamford Connecticut 06902 —
Meridien Research St. Petersburg Florida 33709 —
Premiere Research Institute West Palm Beach Florida 33407 —
Diamond Headache Clinic Chicago Illinois 60614 —
NE Medical Research Associates, Inc. North Dartmouth Massachusetts 02747 —
Michigan Head Pain and Neurological Institute Ann Arbor Michigan 48104 —
Clinical Research Institute Plymouth Minnesota 55441 —
Headache Care Center Springfield Missouri 65807 —
Mercy Health Reserach / Ryan Headache Center St Louis Missouri 63141 —
University Headache Center Chapel Hill North Carolina 27599 —
Headache Wellness Center Greensboro North Carolina 27401 —
North Carolina Clinical Research Raleigh North Carolina 27607 —
Jefferson Headache Center Philadelphia Pennsylvania 19107 —
Clinical Research Associates, Inc. Nashville Tennessee 37203 —
Houston Headache Clinic Houston Texas 77004 —
Jean Brown Research Salt Lake City Utah 84124 —
The Innovative Clinical Research Center Alexandria Virginia 22304 —
Swedish Pain Center Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00293657, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 3, 2012 · Synced Nov 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.